MIRA
NASDAQ · Pharmaceuticals
Mira Pharmaceuticals Inc
$0.92
-0.10 (-9.80%)
Open$1.02
Previous Close$1.02
Day High$1.09
Day Low$0.90
52W High$2.45
52W Low$0.73
Volume—
Avg Volume137.7K
Market Cap42.71M
P/E Ratio—
EPS$-0.40
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,403.3% upside
Current
$0.92
$0.92
Target
$23.03
$23.03
$12.17
$23.03 avg
$29.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.23M | 13.68M | 17.07M |
| Net Income | 2.05M | 2.22M | 2.28M |
| Profit Margin | 13.5% | 16.2% | 13.3% |
| EBITDA | 4.17M | 3.79M | 4.72M |
| Free Cash Flow | 3.12M | 1.71M | 2.33M |
| Rev Growth | +3.2% | +10.2% | +2.3% |
| Debt/Equity | 0.43 | 0.37 | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |